V. Chamouard

501 total citations
34 papers, 348 citations indexed

About

V. Chamouard is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, V. Chamouard has authored 34 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 4 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in V. Chamouard's work include Hemophilia Treatment and Research (22 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Platelet Disorders and Treatments (7 papers). V. Chamouard is often cited by papers focused on Hemophilia Treatment and Research (22 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Platelet Disorders and Treatments (7 papers). V. Chamouard collaborates with scholars based in France, United States and United Kingdom. V. Chamouard's co-authors include Claude Négrier, Anne Lienhart, Yesim Dargaud, Sandrine Meunier, Olivier Héquet, Massimo Morfini, C Petiau, Catherine Delanöe, Françoise Bressolle and Roselyne Boulieu and has published in prestigious journals such as Thrombosis and Haemostasis, Vox Sanguinis and Haemophilia.

In The Last Decade

V. Chamouard

30 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Chamouard France 10 234 58 45 31 24 34 348
Manisha Shrivastava India 8 124 0.5× 26 0.4× 16 0.4× 21 0.7× 8 0.3× 19 293
B. Wibaut France 10 228 1.0× 60 1.0× 22 0.5× 47 1.5× 31 307
Joaquín Santolaya United States 12 23 0.1× 14 0.2× 98 2.2× 25 0.8× 7 0.3× 17 405
J A Robert Chile 5 47 0.2× 14 0.2× 40 0.9× 28 0.9× 5 0.2× 10 299
Salwa Khan United States 6 122 0.5× 21 0.4× 21 0.5× 17 0.5× 9 228
Albertine E. Donker Netherlands 8 159 0.7× 57 1.0× 15 0.3× 17 0.5× 15 248
Kerry L. O’Brien United States 10 123 0.5× 38 0.7× 21 0.5× 46 1.5× 24 278
Betty Thames United States 8 104 0.4× 17 0.3× 39 0.9× 5 0.2× 12 517
Olivier Dunand France 9 34 0.1× 27 0.5× 25 0.6× 5 0.2× 36 1.5× 22 263
Catherine Moltzan Canada 6 125 0.5× 31 0.5× 27 0.6× 27 0.9× 10 216

Countries citing papers authored by V. Chamouard

Since Specialization
Citations

This map shows the geographic impact of V. Chamouard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Chamouard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Chamouard more than expected).

Fields of papers citing papers by V. Chamouard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Chamouard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Chamouard. The network helps show where V. Chamouard may publish in the future.

Co-authorship network of co-authors of V. Chamouard

This figure shows the co-authorship network connecting the top 25 collaborators of V. Chamouard. A scholar is included among the top collaborators of V. Chamouard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Chamouard. V. Chamouard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Bacchetta, Justine, V. Chamouard, Valérie Dubois, et al.. (2023). IVIg therapy in the management of BK virus infections in pediatric kidney transplant patients. Archives de Pédiatrie. 30(3). 165–171. 2 indexed citations
5.
Trossaërt, Marc, V. Chamouard, Christine Biron‐Andréani, et al.. (2023). Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders. European Journal Of Haematology. 110(6). 584–601. 17 indexed citations
6.
Lienhart, Anne, et al.. (2021). Haemophilia A patients' medication adherence to prophylaxis with efmoroctocog alfa. Haemophilia. 27(3). e368–e375. 3 indexed citations
7.
Chamouard, V., et al.. (2021). Patients’ Perception of the Impact of Innovation on Hemophilia Care Management Organization: A Qualitative Study Protocol (INNOVHEMO Study). Patient Preference and Adherence. Volume 15. 1807–1815. 1 indexed citations
8.
Rugeri, Lucia, Marc Fouassier, Anne Lienhart, et al.. (2020). Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real‐life experience. Haemophilia. 26(6). e349–e352. 1 indexed citations
9.
10.
11.
Janoly-Duménil, A., et al.. (2015). Interventions des pharmaciens sur les prescriptions ambulatoires dans le cadre de l’activité de rétrocession d’un centre hospitalier universitaire. Annales Pharmaceutiques Françaises. 73(4). 297–306. 10 indexed citations
12.
Bressolle, Françoise, et al.. (2014). POPULATION PHARMACOKINETICS OF CONTINUOUS INFUSION OF FACTOR VIII IN HEMOPHILIA-A PATIENTS UNDERGOING ORTHOPEDIC SURGERY. International Journal of Pharmacy and Pharmaceutical Sciences. 7(2). 109–114. 2 indexed citations
13.
Dargaud, Yesim, et al.. (2012). Seventy‐two total knee arthroplasties performed in patients with haemophilia using continuous infusion. Vox Sanguinis. 104(2). 135–143. 32 indexed citations
14.
Armoiry, Xavier, et al.. (2010). Contrat de bon usage : mise en œuvre opérationnelle des référentiels de bon usage aux hospices civils de Lyon. Annales Pharmaceutiques Françaises. 68(3). 148–156. 3 indexed citations
15.
Meyer, Éric P., V. Chamouard, M. Berthel, et al.. (2010). Gestion d’une épidémie de gale aux Hôpitaux universitaires de Strasbourg. Médecine et Maladies Infectieuses. 41(2). 92–96. 13 indexed citations
16.
Chamouard, V., et al.. (2007). A Limited Sampling Strategy for Estimating Individual Pharmacokinetic Parameters of Coagulation Factor VIII in Patients With Hemophilia A. Therapeutic Drug Monitoring. 29(1). 20–26. 29 indexed citations
17.
Morfini, Massimo, et al.. (2006). The pharmacokinetics of coagulation factors. Haemophilia. 12(s3). 1–7. 35 indexed citations
18.
Chamouard, V., et al.. (2001). Stability and microbiological safety of clotting factor concentrates in CADD PRIZM VIP™ pump: a preliminary study. Journal de Pharmacie Clinique. 20(3). 2 indexed citations
19.
Petiau, C, et al.. (1993). Somnolence et syndrome d'apnées du sommeil. Analyse de 188 questionnaires (102 malades et 86 témoins). Neurophysiologie Clinique. 23(1). 77–85. 7 indexed citations
20.
Petiau, C, et al.. (1993). Nocturnal Pollakiuria Is a Symptom of Obstructive Sleep Apnea. Urologia Internationalis. 50(2). 93–97. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manisha Shrivastava Breakdown of academic impact, for papers by B. Wibaut Breakdown of academic impact, for papers by Joaquín Santolaya Breakdown of academic impact, for papers by J A Robert Breakdown of academic impact, for papers by Salwa Khan Breakdown of academic impact, for papers by Albertine E. Donker Breakdown of academic impact, for papers by Kerry L. O’Brien Breakdown of academic impact, for papers by Betty Thames Breakdown of academic impact, for papers by Olivier Dunand Breakdown of academic impact, for papers by Catherine Moltzan
Rankless by CCL
2026